Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-09-06 Purchase |
2022-09-08 6:51 pm |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
55,573 | $4.1326 | $229,662 | 371,708 (Indirect Direct) |
View |
2022-08-31 Purchase |
2022-09-02 7:35 pm |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
37,196 | $3.7379 | $139,036 | 316,135 (Indirect Direct) |
View |
2022-08-24 Purchase |
2022-08-26 8:48 pm |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
44,527 | $3.749 | $166,930 | 278,939 (Indirect Direct) |
View |
2022-08-19 Purchase |
2022-08-23 8:19 pm |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
234,221 | $3.328 | $779,477 | 234,412 (Indirect Direct) |
View |
2022-06-13 Purchase |
2022-06-17 4:14 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner |
88,154 | $3.0912 | $272,506 | 1,741,894 (Indirect Direct) |
View |
2021-11-17 Purchase |
2021-11-19 4:10 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO |
400,000 | $0.985 | $394,000 | 16,531,891 (Indirect Direct) |
View |
2021-08-18 Purchase |
2021-08-20 4:27 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO |
480,000 | $1.2788 | $613,800 | 16,137,413 (Indirect Direct) |
View |
2021-03-26 Purchase |
2021-03-30 4:52 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO |
3,000,000 | $2.05 | $6,150,000 | 15,657,413 (Indirect Direct) |
View |
2020-12-16 Purchase |
2020-12-18 4:05 pm |
CASI Pharmaceuticals Inc. | CASI | Xu Weihao Chief Financial Officer |
6,000 | $2.5695 | $15,417 | 810,000 (Indirect Direct) |
View |
2020-11-20 Purchase |
2020-11-24 5:39 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO |
227,471 | $2.1464 | $488,239 | 13,037,413 (Indirect Direct) |
View |
2020-07-22 Purchase |
2020-07-24 4:05 pm |
CASI Pharmaceuticals Inc. | CASI | Zhang Larry President |
20,153 | $1.9 | $38,291 | 20,153 (Direct) |
View |
2020-07-22 Purchase |
2020-07-24 4:03 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner |
4,152,426 | $1.9 | $7,889,609 | 12,809,942 (Indirect Direct) |
View |
2020-05-19 Purchase |
2020-05-21 5:01 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner |
86,265 | $2.2525 | $194,316 | 8,657,516 (Indirect Direct) |
View |
2020-05-15 Purchase |
2020-05-19 5:55 pm |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner |
438,932 | $1.9744 | $866,643 | 8,571,251 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-07 Option Award |
2022-09-09 4:01 pm |
N/A 2031-05-25 |
CASI Pharmaceuticals Inc. | CASI | Zukiwski Alexander A EVP and Chief Medical Officer |
3,000 | $0 | 3,000 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 4:24 pm |
N/A 2032-05-25 |
CASI Pharmaceuticals Inc. | CASI | Zhou Quan Director |
380,645 | $0 | 380,645 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 4:23 pm |
N/A 2032-05-25 |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
397,419 | $0 | 397,419 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 4:13 pm |
N/A 2032-05-25 |
CASI Pharmaceuticals Inc. | CASI | Wu Yue Alexander Director |
388,387 | $0 | 388,387 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 4:12 pm |
N/A 2032-05-25 |
CASI Pharmaceuticals Inc. | CASI | Salisbury Franklin Cary jr Director |
388,387 | $0 | 388,387 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 4:11 pm |
N/A 2032-05-25 |
CASI Pharmaceuticals Inc. | CASI | SHROTRIYA RAJESH C MD Director |
345,806 | $0 | 345,806 (Direct) |
View |
2021-12-02 Option Award |
2021-12-06 4:12 pm |
N/A 2031-12-02 |
CASI Pharmaceuticals Inc. | CASI | Zukiwski Alexander A Chief Medical Officer |
500,000 | $0 | 500,000 (Direct) |
View |
2021-07-24 Option Award |
2021-07-26 6:08 pm |
N/A 2031-07-24 |
CASI Pharmaceuticals Inc. | CASI | Zhang Larry President |
800,000 | $0 | 800,000 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:02 pm |
N/A 2031-06-15 |
CASI Pharmaceuticals Inc. | CASI | Zhou Quan Director |
108,257 | $0 | 108,257 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:02 pm |
N/A 2031-06-15 |
CASI Pharmaceuticals Inc. | CASI | Wu Yue Alexander Director |
110,459 | $0 | 110,459 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:02 pm |
N/A 2031-06-15 |
CASI Pharmaceuticals Inc. | CASI | SHROTRIYA RAJESH C MD Director |
98 | $0 | 98,349 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:02 pm |
N/A 2031-06-15 |
CASI Pharmaceuticals Inc. | CASI | Salisbury Franklin Cary jr Director |
110,459 | $0 | 110,459 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:01 pm |
N/A 2031-06-15 |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
113,028 | $0 | 113,028 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:01 pm |
N/A 2031-04-27 |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner |
4,000,000 | $0 | 4,000,000 (Direct) |
View |
2020-12-22 Gift |
2020-12-23 4:02 pm |
N/A N/A |
CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO |
380,000 | $0 | 12,657,413 (Direct) |
View |
2020-12-16 Option Award |
2020-12-18 4:05 pm |
N/A 2030-12-16 |
CASI Pharmaceuticals Inc. | CASI | Xu Weihao Chief Financial Officer |
800,000 | $0 | 810,000 (Direct) |
View |
Ownership |
2020-12-18 4:05 pm |
N/A N/A |
CASI Pharmaceuticals Inc. | CASI | Xu Weihao Chief Financial Officer |
0 | $0 | 4,000 (Indirect) |
View |
2020-06-16 Option Award |
2020-06-18 06:07 am |
N/A 2030-06-16 |
CASI Pharmaceuticals Inc. | CASI | Zhou Quan Director |
67,429 | $0 | 67,429 (Direct) |
View |
2020-06-16 Option Award |
2020-06-18 06:05 am |
N/A 2030-06-16 |
CASI Pharmaceuticals Inc. | CASI | Huang James Director |
70,400 | $0 | 70,400 (Direct) |
View |
2020-06-16 Option Award |
2020-06-18 06:04 am |
N/A 2030-06-16 |
CASI Pharmaceuticals Inc. | CASI | Wu Yue Alexander Director |
68,800 | $0 | 68,800 (Direct) |
View |
2020-06-16 Option Award |
2020-06-18 06:03 am |
N/A 2030-06-16 |
CASI Pharmaceuticals Inc. | CASI | Salisbury Franklin Cary jr Director |
68,800 | $0 | 68,800 (Direct) |
View |
2020-06-16 Option Award |
2020-06-18 06:02 am |
N/A 2030-06-16 |
CASI Pharmaceuticals Inc. | CASI | SHROTRIYA RAJESH C MD Director |
61,257 | $0 | 61,257 (Direct) |
View |